SARS-CoV-2 (COVID-19) Spike S1 antibody [HL6]
GTX635654
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Spike S1 antibody [HL6]
- Delivery Days Customer9
- Antibody SpecificityThis antibody detects SARS-CoV-2 Spike protein, but does not cross-react with SARS-CoV or MERS-CoV spike proteins based on our internal testing.
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHL6
- Concentration1 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- SARS-CoV-2 spike protein enhances MAP4K3/GLK-induced ACE2 stability in COVID-19. Chuang HC et al., 2022 Sep 7, EMBO Mol MedRead more
- Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Chen Y et al., 2022 May 27, Sci AdvRead more
- Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques. Deng W et al., 2022 Apr 18, Signal Transduct Target TherRead more
- Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection. Kim HK et al., 2022 Apr, BiomaterialsRead more
- Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta. Reagan-Steiner S et al., 2022 Mar, Emerg Infect DisRead more
- Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Song Z et al., 2022 Jan 28, Signal Transduct Target TherRead more
- Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors. Park SB et al., 2022 Jan 11, mBioRead more
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Saito A et al., 2022 Feb, NatureRead more
- A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Danics K et al., 2021 Oct, GeroscienceRead more
- SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Motozono C et al., 2021 Jul 14, Cell Host MicrobeRead more